Forge Life Science Partners

Activity in this selectionlongwood-fund-1a7d6749

By stage

Series B2

Series A1

Biotech3

United States3

3 in this selection

Aug 13

Develops oral small molecule therapies for immunological and chronic diseases

$50MSeries B

Role not disclosed

Aug 11

Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease

$75MSeries A

Role not disclosed

Jan 10

Develops inhaled therapies for severe respiratory diseases

$103MSeries B

Role not disclosed